IGF2 and early-onset autosomal dominant Alzheimer disease: Patients with Alzheimer’s disease (AD) have decreased IGF-2 expression (compared with control subjects) in some brain regions, as was demonstrated in a number of studies using post-mortem brain samples [19,20,21].